POST-PV MF
Clinical trials for POST-PV MF explained in plain language.
Never miss a new study
Get alerted when new POST-PV MF trials appear
Sign up with your email to follow new studies for POST-PV MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink spleens and ease symptoms in myelofibrosis patients
Disease control Recruiting nowThis study tests whether adding navtemadlin to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis who didn't get enough benefit from ruxolitinib. About 600 adults with high- or intermediate-risk myelofibrosis will take part. The goal i…
Matched conditions: POST-PV MF
Phase: PHASE3 • Sponsor: Kartos Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study follows 5,000 adults with myeloproliferative neoplasms (MPNs) — rare blood cancers — to understand how symptoms change and how the disease progresses over years. Participants share their health records, insurance data, and regular surveys about how they feel. No new tr…
Matched conditions: POST-PV MF
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 04, 2026 16:17 UTC